ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 43675 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 43675; 2) Community: the network communities that were significantly associated with the response to NSC 43675; 3) Molecule: the relationships between components within communities and NSC 43675; 4) MDR: the compounds that were significantly associated with the NSC 43675.

NSC Compound Enrichment Correlation
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0112425217758229 -0.4010053
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0115521552688255 0.56845145
NSC 613011 Latrunculin A 0.0115521552688255 -0.13488281
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0115521552688255 0.51619383
NSC 629868 Null 0.0115521552688255 -0.22240325
NSC 630608 Null 0.0115521552688255 0.56484432
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.0115521552688255 0.56010468
NSC 635922 Null 0.0115521552688255 0.57995582
NSC 645317 Sanguilutine pseudobase 0.0115521552688255 0.46749478
NSC 657561 (Z)-4-bromo-4-iodo-3-phenyl-3-buten-2-one 0.0115521552688255 0.43553698
Total:112  Current:38    [First] [Prev] [Next] [Last]